1. Home
  2. VYGR vs GASS Comparison

VYGR vs GASS Comparison

Compare VYGR & GASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • GASS
  • Stock Information
  • Founded
  • VYGR 2013
  • GASS 2004
  • Country
  • VYGR United States
  • GASS Greece
  • Employees
  • VYGR N/A
  • GASS N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • GASS Marine Transportation
  • Sector
  • VYGR Health Care
  • GASS Consumer Discretionary
  • Exchange
  • VYGR Nasdaq
  • GASS Nasdaq
  • Market Cap
  • VYGR 231.9M
  • GASS 272.4M
  • IPO Year
  • VYGR 2015
  • GASS 2005
  • Fundamental
  • Price
  • VYGR $4.21
  • GASS $7.29
  • Analyst Decision
  • VYGR Strong Buy
  • GASS
  • Analyst Count
  • VYGR 8
  • GASS 0
  • Target Price
  • VYGR $16.71
  • GASS N/A
  • AVG Volume (30 Days)
  • VYGR 635.7K
  • GASS 173.4K
  • Earning Date
  • VYGR 11-11-2025
  • GASS 08-25-2025
  • Dividend Yield
  • VYGR N/A
  • GASS N/A
  • EPS Growth
  • VYGR N/A
  • GASS N/A
  • EPS
  • VYGR N/A
  • GASS 1.64
  • Revenue
  • VYGR $42,580,000.00
  • GASS $173,172,375.00
  • Revenue This Year
  • VYGR N/A
  • GASS $2.94
  • Revenue Next Year
  • VYGR $107.07
  • GASS $3.49
  • P/E Ratio
  • VYGR N/A
  • GASS $4.46
  • Revenue Growth
  • VYGR N/A
  • GASS 13.82
  • 52 Week Low
  • VYGR $2.65
  • GASS $4.82
  • 52 Week High
  • VYGR $8.28
  • GASS $8.18
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 62.64
  • GASS 52.07
  • Support Level
  • VYGR $3.91
  • GASS $7.18
  • Resistance Level
  • VYGR $4.51
  • GASS $7.55
  • Average True Range (ATR)
  • VYGR 0.27
  • GASS 0.22
  • MACD
  • VYGR 0.05
  • GASS -0.05
  • Stochastic Oscillator
  • VYGR 74.79
  • GASS 14.47

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

Share on Social Networks: